Serodin

Quick links to important sections

Serodin

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Serodin

Quick Facts

Property Description
Active ingredient Chorionic Gonadotropin (hCG)
Form Powder for Solution for Injection
Pharmacological class Gonadotropin Hormone
Common use Stimulating gonadal functions
Origin Naturally-derived biological product

What is Serodin and What Type of Drug is it?

Serodin is a pharmaceutical preparation containing the active ingredient Chorionic Gonadotropin (hCG), and it is formally classified as a gonadotropin hormone therapy. This medication belongs to the class of polypeptide hormones that function as key messengers for signaling and regulating processes in the reproductive system. The active substance, Chorionic Gonadotropin, is structurally recognized as a glycoprotein hormone composed of two subunits, which enables it to interact directly with the Lutropin-choriogonadotropic hormone receptor. Pharmacological studies have widely confirmed that the action of hCG is virtually identical to that of the body's natural Luteinizing Hormone (LH), making Serodin a potent and clinically recognized substitute for LH activity.

Composition, Origin, and Preparation Form

Serodin is distinguished as a naturally-derived biological product because its active ingredient is typically purified from a natural source, differentiating it from purely synthetic compounds. The official classification identifies Chorionic Gonadotropin as a therapeutic hormone used in reproductive medicine. As a single-compound preparation, Serodin is most commonly supplied as a sterile powder for solution for injection. Due to its protein-based nature, this injectable form is required, and the medicine is administered via intramuscular injection or subcutaneous injection.

What is the General Purpose of Chorionic Gonadotropin?

Its general purpose is to provide a potent, targeted hormonal signal to stimulate gonadal functions—specifically, in the ovaries and the testes. By delivering this strong signal, the medication is clinically recognized for helping to initiate or support critical biological events, such as the production of essential steroid hormones. Research has established the pharmacological class of gonadotropins as essential for regulating reproductive hormones in both men and women. The simple conclusion is that this medicine helps trigger or sustain the hormone activity needed for the body’s reproductive cycles.

What side effects are possible with Serodin?

Serodin (which may refer to a combination of Diclofenac and Serratiopeptidase, or a product containing Paracetamol, Propyphenazone, and Caffeine) is generally well-tolerated when used as directed. However, like all medications, it can cause side effects.

Common Side Effects

Side effects that are frequently reported, especially related to the gastrointestinal system, may include:

  • Nausea and/or Vomiting
  • Stomach upset or Heartburn
  • Abdominal pain
  • Diarrhea
  • Dizziness or Headache

Serious Side Effects and Warnings

While rare, immediate medical attention should be sought if you experience signs of serious adverse reactions. These can involve the liver, kidneys, or indicate an allergic response:

  • Signs of a severe allergic reaction (e.g., difficulty breathing, swelling of the face/throat, severe skin rash, blisters, or peeling).
  • Signs of liver problems (e.g., yellowing of the skin or eyes, dark urine, persistent nausea, or vomiting).
  • Signs of gastrointestinal bleeding or ulceration (e.g., black/tarry stools, vomiting blood, or what looks like coffee grounds).
  • Unusual or easy bruising or bleeding.

Contraindications and Precautions

Before taking Serodin, inform your healthcare provider if you have a history of:

  • Allergy to the components of Serodin or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
  • Stomach or intestinal ulcers or bleeding.
  • Severe heart failure, high blood pressure, or recent heart attack.
  • Liver or kidney disease.
  • Pregnancy or breastfeeding.

It is crucial to follow the prescribed dosage and not exceed the recommended maximum daily dose, as overdose, particularly of the paracetamol component, can cause severe liver damage.

Overdose and Emergency Response

The official regulatory profile for Serodin (Chorionic Gonadotropin) overdose focuses on the risk of Ovarian Hyperstimulation Syndrome (OHSS), a condition explicitly documented as potentially life-threatening. Over-administration is associated with the development of severe OHSS, primarily in female patients undergoing ovarian stimulation.

Documented Manifestations and Severe Outcomes Signs of overexposure documented in regulatory labeling include severe pelvic pain, abdominal distension, rapid weight gain, and gastrointestinal symptoms such as vomiting and diarrhea. Severe outcomes explicitly noted are thromboembolic events (blood clots), pulmonary complications (like pleural effusion), and hypovolemia. In prepubertal boys, excessive dosing may induce signs of precocious puberty.

Emergency Actions and Management Regulatory guidance mandates that patients seek immediate medical attention upon suspicion of over-administration or if symptoms indicative of severe OHSS rapidly develop. This includes symptoms like severe abdominal discomfort or shortness of breath. Treatment should be discontinued immediately. The official approach to management is symptomatic and supportive, which may involve hospitalization and close monitoring of fluid balance, serum electrolytes, and renal function. Regulatory documents state that no specific antidote is known for Chorionic Gonadotropin overdose.

Therapeutic Uses of Serodin

Serodin, which contains Chorionic Gonadotropin, is relevant for managing conditions characterized by specific reproductive and developmental issues. Its therapeutic scope is aligned with addressing clinical situations that require hormonal support.

This medication is commonly used to help manage conditions presenting with systemic or localized discomfort, including: anovulatory infertility in women, hypogonadotropic hypogonadism in men, and cryptorchidism (undescended testicles) in boys. It is applied during phases of increased distress or discomfort associated with these conditions, supporting the patient during difficult episodes by easing the overall symptom load.

Induction of Ovulation in Anovulatory Infertility

This application helps address symptom clusters that may become disruptive by assisting with the ovulatory cycle, a necessary step in assisted reproductive procedures.

Management of Endogenous Hormonal and Reproductive Symptoms

The therapeutic benefit is used for managing conditions where the functional stability of the reproductive system is a primary clinical concern.


Quick Fact: Relief for Reproductive Symptoms

Focus Area Symptom Domain Addressed
Female Fertility Absent or irregular ovulation
Male Reproduction Low sperm count and related symptoms
Pediatric Development Delayed sexual maturation and testicular descent

Eligibility and Restrictions for Use

The eligibility for using Serodin (Chorionic Gonadotropin) is strictly determined by regulatory labeling, which outlines approved populations, absolute contraindications, and conditional use restrictions.

Eligibility Scope

Population Status Classification & Groups (Official Regulatory Basis)
Allowed Adult Women and Adult Men for specific documented indications; Prepubertal Boys for cryptorchidism not due to anatomical obstruction.
Contraindicated Patients with a prior hypersensitivity reaction to Chorionic Gonadotropin or its excipients.
Contraindicated Patients with sex hormone-dependent tumors (e.g., prostatic carcinoma or carcinoma of the breast, ovary, or uterus).
Contraindicated Women with Primary Ovarian Failure or men with Primary Testicular Failure, as treatment is incompatible with the condition.
Contraindicated Pregnant Women and those with Active Thromboembolic Disorders or certain reproductive tract malformations.

Age and Condition Rules

Eligibility Group Restriction Status (Official Regulatory Basis)
Pediatric (Under 4) Safety and effectiveness have not been established.
Geriatric No relevant use is documented.
Renal/Hepatic Impairment Safety, efficacy, and pharmacokinetics have not been established.
Cardiovascular/Renal Disease Use requires caution due to the possibility of fluid retention.

Connection to the overall eligibility profile

Regulatory documents strictly define who can and cannot use the medicine by setting absolute prohibitions based on malignancy and primary gonadal dysfunction, and by establishing contraindications based on physiological states such as pregnancy. Eligibility is further restricted through mandatory caution in populations prone to fluid retention or thromboembolic events, and it is explicitly stated that use is not established in patients with certain organ function impairments or in the youngest age groups.

What should I know about interactions with other medicines?

Official Interaction Status for Co-administered Medicines

The regulatory profile for Serodin (Chorionic Gonadotropin) is largely defined by a fundamental lack of formalized data regarding co-administration with other medicinal products. Official documentation explicitly states that formal drug-drug interaction studies have not been conducted or investigated. This regulatory status dictates the findings across many common interaction categories.

As a result, regulatory labels do not specify any medicinal product categories that are strictly classified as contraindicated combinations due to interaction risk. Furthermore, there are no documented interactions that affect the pharmacokinetic exposure of Serodin, such as enzyme-mediated changes in the Cmax or AUC of the drug. The regulatory documents also do not contain mandatory timing-separation rules requiring doses to be administered apart by a set number of hours.

Interaction with Diagnostic Products

The only documented constraint in the official interaction profile relates to procedural considerations during diagnosis. Chorionic Gonadotropin may interfere with radioimmunoassay for gonadotropins, specifically for measuring Luteinizing Hormone (LH). This interaction is important because the drug's presence can lead to inaccurate or falsely elevated readings of the body’s endogenous hormone levels when these specific diagnostic products are utilized. This procedural constraint represents the primary focus of the regulatory interaction profile.

Mechanism of Action

Central and Peripheral Mechanism of Action

Serodin's mechanism of action involves modulating key pathways in both the central nervous system (CNS) and peripheral tissues. It works primarily by inhibiting specific Cyclooxygenase (COX) enzymes to limit the synthesis of prostaglandins, which are molecules that influence sensory nerve depolarization and hypothalamic setpoint activity. This inhibition modifies early molecular steps that shape systemic physiological outcomes, resulting in the modulation of pathway activity.


Modulating Signaling and Systemic Enhancement

The mechanism also involves affecting systems where a distinct transmitter dominates, specifically through antagonism of adenosine receptors in the CNS. This action alters CNS signaling patterns and modifies pathway activity that may escalate under certain conditions. Furthermore, this component modifies signaling dynamics within targeted pathways by accelerating the onset of action and bioavailability of the co-administered compounds. This results in physiologic alterations contributing to the final systemic response.

Dosage and Administration Information

Administration Methods

Serodin is typically administered orally. The method of intake depends on the specific formulation provided, such as immediate-release tablets, extended-release capsules, or oral solutions.

Oral Tablets and Capsules

When taking the tablet or capsule form, the medication is generally swallowed whole with water. Some formulations are designed to release the active ingredients over a specific period. Altering the physical form of these medications by crushing, chewing, or breaking them can change how the substance is absorbed into the bloodstream.

Oral Solution

For the liquid form of the medication, a calibrated measuring device is used to ensure the volume is consistent with the intended application. Standard household spoons are not typically used for measurement due to variations in size and volume accuracy.

Timing and Consistency

Maintaining a consistent schedule is a primary factor in the use of Serodin. This involves taking the medication at the same time each day to help keep a steady level of the substance in the body.

Relationship with Food

Serodin may be taken either with or without food, depending on the specific requirements of the formulation. Some individuals find that taking the medication with a meal helps with gastrointestinal comfort, while others may be advised to take it on an empty stomach to facilitate absorption.

Handling and Storage

Proper handling of the medication ensures its integrity. It is important to keep the container tightly closed when not in use and to store it in an environment that is protected from excessive heat, moisture, and direct sunlight.

Missing a Session

If a scheduled application is missed, the standard approach is to resume the regular schedule at the next designated time. Taking multiple doses simultaneously to compensate for a missed one is generally avoided to maintain a stable physiological environment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Serodin

The clinical evaluation of Serodin, which contains the hormone Chorionic Gonadotropin (hCG), is based on research exploring its studied effects in specific patient populations. The evidence is derived from multiple types of studies, including controlled trials, observational studies, and comprehensive scientific reviews.


Evidence for Use in Ovulation Induction (Infertility)

Research examined the use of Chorionic Gonadotropin in adult women with conditions that prevent or disrupt regular ovulation, such as Polycystic Ovarian Syndrome (PCOS). Studies were primarily designed as short-term Randomized Controlled Trials (RCTs) that monitored key reproductive outcomes. Findings describe patterns observed when the medication was applied to promote final follicular rupture as part of structured assisted reproductive protocols. Research describes short-term changes monitored in the study period, including the frequency of achieving a clinical pregnancy.

Evidence for Use in Male Hypogonadotropic Hypogonadism

The research in males, including adolescent and young adult males with hormonal deficiency, has primarily relied on Retrospective Analyses and extended Observational Cohort Studies. Studies monitored physiological outcomes such as changes in testicular volume, the increase in serum testosterone concentrations, and the eventual initiation of spermatogenesis (sperm production). Studies report how hormonal markers evolved in the observed populations over defined time intervals.


Study Quality, Consistency, and Research Gaps

The research base is characterized by studies of varying quality. While certain indications are supported by multiple RCTs, others rely more on small, non-randomized observational settings. A primary limitation is the heterogeneity of the evidence, where differing protocols and patient selection criteria lead to mixed findings. Overall, evidence addressing comparisons is lacking for many long-term endpoints across all indications. Long-term effects related to reproductive and general health are not fully established across all indications.

Frequently Asked Questions (FAQ)

Common questions about Serodin (FAQ)


Q: Are there any common over-the-counter medicines that interact with Serodin?

Official regulatory documents indicate that formal drug-drug interaction studies have not been conducted for Serodin with other medicinal products, including those sold over the counter. This means the specific effects of combining it with OTC medicines are not formally detailed in the label. Information regarding concurrent use of any medications is typically reviewed by a healthcare provider.


Q: Can Serodin interact with herbal supplements like St. John's wort?

Official documentation does not specify interactions with herbal or dietary supplements. Similar to other medicines, the regulatory labeling notes that formal interaction studies have not been conducted for Serodin (Chorionic Gonadotropin). It is recommended to inform a healthcare provider of any supplements being taken.


Q: How quickly does Serodin start to work?

The regulatory information describes the pharmacokinetic profile of Serodin, which includes data on the time it takes for the drug concentration to reach its maximum level in the body following administration. This data provides insight into the earliest point of systemic action. The time to see a clinical effect is described as being variable depending on the individual and the condition being treated.


Q: Is Serodin known to cause weight gain?

Official documents list edema (fluid retention) as an infrequent or uncommon adverse reaction associated with the medication’s use. Edema, which is excess fluid accumulating in the tissues, can sometimes lead to changes in body weight. Official labeling indicates that use requires caution in patients prone to fluid retention, such as those with pre-existing kidney or cardiovascular disease.


Q: Can Serodin cause sleep problems like insomnia?

While the term insomnia may not be directly listed, regulatory labeling may include associated symptoms related to central nervous system effects, such as restlessness or irritability, as possible reactions.


Q: What's the difference between Serodin and similar medicines like [Competitor Drug 1]?

Official sources classify Serodin as a gonadotropin hormone therapy. Its action is formally described as being virtually identical to that of the body's natural Luteinizing Hormone (LH), which defines its role in the treatment class.


Q: Does Serodin affect mood swings?

Official regulatory documents list certain psychiatric or central nervous system adverse reactions as possible effects that have been reported in clinical data. These include effects such as irritability, restlessness, or depression.


Q: Is it okay to take Serodin if I drink coffee daily?

Regulatory documents state that the medication's parenteral administration (injection) is independent of meal timing. Since formal interaction studies have not been conducted, specific formal data or advice on the concurrent use of caffeine or coffee is often not provided.


Q: How long after starting Serodin should I expect to see an effect?

Official research descriptions discuss the expected timeframe by detailing study durations, which range from short-term trials to multi-month courses, depending on the specific approved use being examined. The time to see an effect is described as being variable depending on the condition being treated and individual physiological response.


Q: What happens if I forget to take a dose of Serodin?

Official instructions for multi-dose regimens, such as those used in male hypogonadism protocols, typically provide procedural guidance on how a forgotten or missed dose should be managed. This guidance is intended for review with the prescribing professional.


Q: Is Serodin addictive or habit-forming?

Serodin (Chorionic Gonadotropin) is a hormone therapy. It is not classified as a controlled substance by regulatory agencies. Therefore, official warnings regarding dependency or habit formation are not included in the labeling.


Q: Does Serodin interact with alcohol?

The official interaction profile states that formal interaction studies have not been conducted for Serodin. For this reason, specific formal advice or warnings regarding concurrent alcohol use are often not provided in the regulatory labeling.


Q: What is the process for stopping Serodin, according to official guidelines?

Official usage guidelines emphasize that the treatment course and the decision to discontinue Serodin should be based on clinical monitoring. Changes to the treatment plan, including discontinuation, are typically managed under the supervision of a healthcare provider.


Q: Does Serodin affect driving or operating machinery?

Official warnings state that if the medication causes certain central nervous system reactions, such as dizziness, it may affect the ability to operate machinery or drive. Caution is advised regarding tasks requiring alertness, such as driving, until the individual response to the drug is known.


Q: Can Serodin make anxiety feel worse initially?

Official regulatory documents list various psychiatric or CNS effects, including anxiety or headache, as possible adverse reactions reported in clinical data related to the medication. These effects are noted as potential adverse reactions.


Q: What happens if I stop taking Serodin suddenly?

Official documents emphasize that the decision to stop Serodin should be made in consultation with a physician. Discontinuation often involves medical supervision because the treatment is part of a specific hormonal protocol and official guidance emphasizes that treatment is generally not intended for abrupt cessation.


Q: What does it mean if Serodin is classified as a 'Schedule [X]' medicine?

Serodin (Chorionic Gonadotropin) is a hormone therapy. It is not listed as a controlled substance under federal regulations. Controlled substance schedules are used for drugs that have a potential for abuse or dependence.


Q: How long does Serodin stay in your system after the last dose?

Official pharmacokinetic data reports the elimination half-life of the medication. The half-life describes the time it takes for half of the drug to be eliminated from the body. This measure is noted as being variable between individuals.


Q: Is there a generic version of Serodin available?

The availability of a generic equivalent is a matter of official regulatory product approval status maintained by government health agencies. This information can be verified in public regulatory databases such as the FDA's Orange Book or similar foreign regulatory registers.


Q: How does Serodin relate to serotonin levels?

Official documentation describing the drug's central and peripheral mechanism of action does not include any known connection or effect on serotonin levels. Serodin functions as a gonadotropin hormone that mimics the action of Luteinizing Hormone (LH).


Q: What is the difference between Serodin and placebo in studies?

Regulatory clinical trial summaries confirm that the medication's use has been examined in Randomized Controlled Trials (RCTs) against a placebo or comparison group. This comparison is the scientific basis used to establish the medication's efficacy.


Q: Does Serodin cause any sexual side effects?

Official adverse reaction documents list specific reproductive system effects, which is expected for a hormone therapy. These possible reactions include signs of gynecomastia (enlargement of breast tissue in males) or ovarian-related changes.


Q: Do I need regular blood tests while on Serodin?

Official guidelines indicate that hormone levels and other physiological markers often require regular clinical monitoring during the course of treatment. This monitoring is generally utilized to track progress and adjust the treatment plan as described in official guidelines.

How should Serodin be stored and disposed of?

Serodin must be stored correctly to maintain its effectiveness and to prevent accidental ingestion. Keep the medication in its original container, sealed, and always store it out of the sight and reach of children and pets. The ideal storage location is a cool, dry place, away from excessive heat, light, and moisture. For instance, do not store it in a bathroom medicine cabinet.

Dispose of any unused or expired Serodin promptly and safely. The preferred method is to utilize a community drug take-back program or a mail-back program provided by an authorized collector. If a take-back option is not readily available, follow the FDA's guidelines for disposal in household trash, unless Serodin is on the flush list. This method typically involves mixing the drug with an undesirable substance, such as used coffee grounds or cat litter, placing the mixture in a sealed container, and then discarding it in the trash. Always remove or obscure personal information on the prescription label before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Serodin found in:

A-Z Index: